A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...

One of the reasons for this dramatic, full-body response is that naloxone binds to opioid receptors all over the body, triggering involvement from organs like the skin and intestines, and not just ...

Fentanyl’s prevalence in the illicit drug market has made overdoses a universal risk, affecting a wide range of students – ...

Billings, compares the state’s purchase of overdose reversal drugs like Narcan from companies that have contributed to the ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...

Opioids work by stimulating opioid receptors in the brain, blocking pain signals. During the process, the brain also floods ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

Using an innovative and recently validated animal model of IBS, the researchers showed that opioid delta-receptor agonists can ameliorate stress-induced IBS symptoms by acting on the insular cortex of ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.